MedTrace Logo

Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine

NCT00503594 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2012-07-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate two types of chemotherapy for primary central nervous system lymphoma in the elderly (age older than 60) :

* Methotrexate, procarbazine, vincristine and cytarabine
* Methotrexate and temozolomide

Conditions

Interventions

DRUG

Methotrexate and temozolomide

Methotrexate and temozolomide

DRUG

Methotrexate , procarbazine ,vincristine ,cytarabine

Methotrexate , procarbazine ,vincristine ,cytarabine

Sponsors & Collaborators

  • French Innovative Leukemia Organisation

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Antonio OMURO, MD, · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2010-07-31
Completion
2012-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00503594 on ClinicalTrials.gov